NATIONAL RESEARCH CORP 4

4 · NATIONAL RESEARCH CORP · Filed Jan 7, 2014

Form 4

Period: 2014-01-07

President and COO

Transactions

Award
Employee Stock Option (right to buy)
2014-01-07+7,112→ 7,112 total
Exercise: $18.80Exp: 2024-01-07→ Class A Common Stock (7,112 underlying)
Award
Employee Stock Option (right to buy)
2014-01-07+653→ 653 total
Exercise: $34.15Exp: 2024-01-07→ Class B Common Stock (653 underlying)

Holdings

Class B Common Stock
3,911
Employee Stock Option (right to buy)
Exercise: $22.96Exp: 2021-07-05→ Class B Common Stock (25,000 underlying)
25,000
Employee Stock Option (right to buy)
Exercise: $27.13Exp: 2023-01-07→ Class B Common Stock (4,464 underlying)
4,464
Class A Common Stock
23,469
Employee Stock Option (right to buy)
Exercise: $11.72Exp: 2021-07-05→ Class A Common Stock (150,000 underlying)
150,000
Employee Stock Option (right to buy)
Exercise: $14.50Exp: 2023-01-07→ Class A Common Stock (26,784 underlying)
26,784

Footnotes (4)

[F1]On May 22, 2013, the Issuer completed a recapitalization pursuant to which it, among other things, issued a stock dividend of three shares of class A common stock for each share of then-existing common stock and reclassified each share of its then-existing common stock as one-half of one share of class B common stock. All fractional shares of class B common stock were cashed-out in the recapitalization. In connection with the recapitalization, the exercise prices of outstanding options were equitably adjusted to prevent the dilution or enlargement of the benefits intended to be provided.
[F2]This option becomes fully exercisable on January 7, 2019.
[F3]This option becomes fully exercisable on July 5, 2016.
[F4]This option becomes fully exercisable on January 7, 2018.

Documents

1 file